EQRR vs. GERM
EQRR (ProShares Equities for Rising Rates ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both exchange-traded funds - EQRR is a Mid Cap Value Equities fund tracking the Nasdaq US Large Cap Equity Rising Rates Index, while GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, EQRR returned 41.70% vs 0.00% for GERM. EQRR charges 0.35%/yr vs 0.68%/yr for GERM.
Performance
EQRR vs. GERM - Performance Comparison
Loading charts...
Returns By Period
EQRR
- 1D
- -0.58%
- 1M
- 8.10%
- YTD
- 27.33%
- 6M
- 27.15%
- 1Y
- 41.70%
- 3Y*
- 22.28%
- 5Y*
- 12.33%
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
EQRR vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
EQRR ProShares Equities for Rising Rates ETF | 27.33% | 15.49% | 1.72% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
EQRR vs. GERM - Sectors Allocation Comparison
Sectors
EQRR
GERM
Technology
-
Energy
-
Financial Services
Communication Services
-
Consumer Cyclical
-
Industrials
-
Basic Materials
-
-
Consumer Defensive
-
-
Healthcare
-
Real Estate
-
-
Utilities
-
-
Technology
EQRR
GERM
-
Energy
EQRR
GERM
-
Financial Services
EQRR
GERM
Communication Services
EQRR
GERM
-
Consumer Cyclical
EQRR
GERM
-
Industrials
EQRR
GERM
-
Basic Materials
EQRR
-
GERM
-
Consumer Defensive
EQRR
-
GERM
-
Healthcare
EQRR
-
GERM
Real Estate
EQRR
-
GERM
-
Utilities
EQRR
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EQRR vs. GERM — Risk / Return Rank
EQRR
GERM
EQRR vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Equities for Rising Rates ETF (EQRR) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EQRR | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.56 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 8.47 | — | — |
| Martin ratioReturn relative to average drawdown | 31.54 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EQRR | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.11 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | — | — |
Drawdowns
EQRR vs. GERM - Drawdown Comparison
The maximum EQRR drawdown since its inception was -57.93%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for EQRR and GERM.
Loading charts...
Drawdown Indicators
| EQRR | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -57.93% | 0.00% | -57.93% |
Max Drawdown (1Y)Largest decline over 1 year | -4.95% | 0.00% | -4.95% |
Max Drawdown (3Y)Largest decline over 3 years | -17.75% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -21.75% | — | — |
Current DrawdownCurrent decline from peak | -0.58% | 0.00% | -0.58% |
Average DrawdownAverage peak-to-trough decline | -10.08% | 0.00% | -10.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.33% | 0.00% | +1.33% |
Volatility
EQRR vs. GERM - Volatility Comparison
ProShares Equities for Rising Rates ETF (EQRR) has a higher volatility of 4.72% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that EQRR's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EQRR | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.72% | 0.00% | +4.72% |
Volatility (6M)Calculated over the trailing 6-month period | 10.35% | 0.00% | +10.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.50% | 0.00% | +13.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.39% | 0.00% | +21.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.87% | 0.00% | +24.87% |
EQRR vs. GERM - Expense Ratio Comparison
EQRR has a 0.35% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
EQRR vs. GERM - Dividend Comparison
EQRR's dividend yield for the trailing twelve months is around 1.20%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
EQRR ProShares Equities for Rising Rates ETF | 1.20% | 1.70% | 2.17% | 2.77% | 2.34% | 1.71% | 2.17% | 2.05% | 2.47% | 0.69% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
EQRR has higher volatility (4.72%) compared to GERM (0.00%). In terms of maximum drawdown, EQRR dropped -57.93% vs GERM's 0.00%.
On 1-year performance, EQRR leads with 41.70% vs 0.00% for GERM. On fees, EQRR is cheaper at 0.35% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, EQRR has performed better with a 41.70% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
EQRR is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.
EQRR has the higher dividend yield at 1.20%, compared with 0.00% for GERM.
EQRR is categorized as Mid Cap Value Equities, while GERM is Health & Biotech Equities. EQRR tracks Nasdaq US Large Cap Equity Rising Rates Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: ProShares and Amplify. Their fees differ too: 0.35% for EQRR and 0.68% for GERM.
Find the right allocation for EQRR and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer